Alexion Pharmaceutical Inc. buy melinda
Start price
15.09.17
/
50%
€132.65
Target price
26.12.17
€175.89
Performance (%)
-18.99%
End price
26.12.17
€107.46
Summary
This prediction ended on 26.12.17 with a price of €107.46. The prediction for Alexion Pharmaceutical Inc. disappointed with a performance of -18.99%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alexion Pharmaceutical Inc. | - | - | - | - |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% | 68.786% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% | 100.066% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% | 43.024% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% | 63.222% |
According to melinda what are the pros and cons of Alexion Pharmaceutical Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Alexion Pharmaceutical Inc. diskutieren
Pharma SecteurProduits
Alexion fügt Paul A. Friedman, MD in den Vorstand
- Der ehemalige Präsident und CEO von Incyte bringt umfangreiche Erfahrung in F & E und Biotechnologie -
(Vom Mitglied beendet)
Stopped prediction by melinda for Alexion Pharmaceutical Inc.
Alexion Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€70.50
12.03.20
12.03.20
€145.00
04.11.21
04.11.21
119.55%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Alexion Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€125.50
29.09.18
29.09.18
€130.79
12.03.20
12.03.20
-43.83%
12.03.20
12.03.20
Could be worthwhile Investment >10% per year
Alexion Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€112.84
09.03.18
09.03.18
€153.34
10.09.18
10.09.18
-6.26%
10.09.18
10.09.18
Could be worthwhile Investment >10% per year